Home › NDC Lookup › RxCUI directory › RxCUI 1293451

Tazarotene 1 MG/ML Topical Foam — RxCUI 1293451

Name: Tazarotene 1 MG/ML Topical Foam (RxCUI 1293451)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1293451 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1293451

Official nameTazarotene 1 MG/ML Topical Foam

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known astazarotene 0.1 % Topical Foam

FDA products mapped2

Package NDCs mapped2

Reported Medicaid activity (SDUD)439 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tazarotene Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It's designed to help reduce the look of fine facial wrinkles, uneven patches of lighter or darker skin, and flat age spots — but it works as part of a bigger picture that includes...
What exactly is tazarotene cream supposed to do for my skin?
Yes, some redness, peeling, burning, and dryness are very common when you first start using tazarotene, and they tend to be most noticeable in the beginning. Your skin often needs...
My skin got really red and peely after I started using it — is that normal?

📖 Read our full Tazarotene Topical guide →

🕸️ Concept Web — How Tazarotene 1 MG/ML Topical Foam Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Tazarotene 1 MG/ML Topical Foam RxCUI 1293451 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Tazarotene 83947 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Fabior 1293452 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Tazarotene Topical Foam 1293450 SCDF
- Tazarotene Topical Product 1160878 SCDG
- Tazarotene Topical Foam [Fabior] 1293454 SBDF
- Fabior Topical Product 1293455 SBDG
- Topical Foam 346285 DF
- Topical Product 1151122 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Tazarotene 1 MG/ML 346293 SCDC
- Tazarotene 1 MG/ML Topical Foam [Fabior] 1293456 SBD
- Tazarotene 1 MG/ML [Fabior] 1293453 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Tazarotene 1 MG/ML SCDC · 346293
Tazarotene Topical Foam SCDF · 1293450
Tazarotene Topical Product SCDG · 1160878

Brand-Name Concepts

Tazarotene 1 MG/ML Topical Foam [Fabior] SBD · 1293456
Tazarotene 1 MG/ML [Fabior] SBDC · 1293453
Tazarotene Topical Foam [Fabior] SBDF · 1293454
Fabior Topical Product SBDG · 1293455
Fabior BN · 1293452

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 1293451 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
51862-0295-10	1 CAN in 1 CARTON (51862-295-10) / 100 g in 1 CAN	FABIOR	Mayne Pharma	2017-03-17
68308-0685-50	1 CAN in 1 CARTON (68308-685-50) / 50 g in 1 CAN	tazarotene	Mayne Pharma Inc.	2021-04-23

Observed labelers: Mayne Pharma (1) · Mayne Pharma Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per gm · median

$12.3228

Range $12.3228–$12.3228 · middle 50% $12.3228–$12.3228 · 1 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.